Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
How to Protect Your Eyesight

How to Protect Your Eyesight

An interview with Dr. Neil Ebenezer from the charity Fight for Sight, discussing the importance of getting regular check ups and why research is still desperately needed for many ophthalmic conditions.

What are the most common causes of vision loss in the developed world?

There are currently over two million people with sight loss in the UK. By far the main causes of sight loss are age-related macular degeneration (AMD), which affects around 600,000 people, glaucoma, which affects around half a million and cataracts, which affects approximately half a million people.

Elderly woman with cataractsCataracts. Image Credit: Africa Studio / Shutterstock

While there is a lot of research in the areas of AMD and glaucoma, much more work needs to be done to tackle these conditions, which is why investment in eye research is so important.

We now have a simple operation that can address cataracts, a condition that previously caused significant sight loss in the UK. This clearly demonstrates that research breakthroughs are achievable and can have a huge impact.

How can people reduce their risk of vision loss?

There are a number of steps people can take to look after their eyes, although unfortunately, it isn’t possible to prevent all types of eye disease.

The most important thing people can do is have eye tests every two years – or more frequently if you’ve been advised to do so. This helps pick up on the early signs of any problems that can then be treated at an early stage.

Also, know your own family history; for example, is there a history of glaucoma in your family? If so you should get our eyes tested more frequently once you are over 40.

Glasses on top of reading chart as part of eye testImage Credit: Alexey Rotanov / Shutterstock

We know that other lifestyle factors can help prevent eye disease too, like regularly cleaning or disposing of wearing contact lenses to prevent infections that can cause sight loss.

It’s also very important to wear UV protective sunglasses to protect your eyes from UV rays. This is particularly important for children under five whose eyes are more vulnerable to UV.

Our own recent research showed that one in two people don’t often wear sunglasses and that they are unaware of the role of UV in contributing to conditions like cataracts and possibly AMD.

Finally, make sure you get exercise and eat healthily. This will help to prevent conditions like diabetes and stroke which themselves can cause eye-related problems.

There’s now some evidence that there’s a direct link between exercise and reduced risk of glaucoma but more research is needed to confirm this.

Why is it important to have regular eye tests, even if you are not experiencing problems with your eyesight?

The NHS recommendation is to have your eyes checked every two years. However, our YouGov research shows that three in ten people don’t do this, and the main reasons given are that they think they ‘can see fine’ or can’t afford it.

It’s really important to have an eye tests even if you think you can see fine because eye tests can pick up on the early signs of eye disease.

Not many people realize that eye tests can also pick up on other health problems; for example, they can help with the early diagnosis of conditions such as diabetes, high blood pressure, and even brain tumors.

What are Fight for Sight doing to address the growing problem of sight loss in the UK?

Put simply, our aim at Fight for Sight is to create a future where everyone can see.

We’ve currently invested 8 million in 160 research projects at 49 universities and hospitals across the UK and we fund projects that address eye conditions like age-related macular degeneration, glaucoma, inherited eye disease and those eye diseases that are linked to other conditions like diabetes and stroke.

Our aim is to invest in pioneering research that could lead to the next breakthrough. For example, we funded the initial research that led to a world first gene therapy clinical trial at Oxford University for an inherited eye condition called choroideremia.

This condition ultimately causes blindness in people with the disease. However, the initial results from the trial show that the treatment has prevented further deterioration in the patients involved and, in some cases, has even restored some sight.

What does the future hold for ophthalmology and eye health?

These are interesting times for eye research, where methods like gene therapy and stem cell research offer huge potential to achieve the impossible.

As the eye is a contained area and separate from the rest of the body it’s an ideal place to test out some of these new techniques, so I expect to see these methods increasingly used to further the area of eye research, which is very exciting for all of us involved in this field.

Unfortunately, eye research as an area is woefully underfunded – our own figures show only one percent of public grant research spending went into eye research in 2017.

While the future is bright for ophthalmology and eye health, we do desperately need more funding in this area to reach the full potential that could be achieved through groundbreaking research, and to raise awareness of basic eye health messages with the general public.

About Dr. Neil Ebenezer

Dr. Neil EbenezerDr. Neil Ebenezer is currently the Director of Research, Policy, and Innovation at Fight for Sight and has a broad scientific knowledge with a degree in Biotechnology, a Ph.D. in Molecular Genetics and over 20 years of experience in the healthcare sector.

Most recently, Dr. Ebenezer was the Head of Science and Innovation at the Department for Transport (DfT) where he developed and managed an innovation portfolio of work to ensure that the Department had access to cutting-edge technologies.

Neil has also represented the MHRA at a European level as part of the New and Emerging Technologies working group.

 

Tagged with:

About author

Related Articles